Gradient Investments LLC raised its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 4.4% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 150,167 shares of the semiconductor company’s stock after purchasing an additional 6,371 shares during the quarter. Lam Research accounts for about 0.9% of Gradient Investments LLC’s portfolio, making the stock its 25th largest position. Gradient Investments LLC’s holdings in Lam Research were worth $65,072,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Norges Bank bought a new stake in shares of Lam Research during the 4th quarter worth approximately $3,645,427,000. Price T Rowe Associates Inc. MD boosted its holdings in Lam Research by 352.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after acquiring an additional 10,666,540 shares during the period. Franklin Resources Inc. grew its position in Lam Research by 57.0% in the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after acquiring an additional 3,671,073 shares during the last quarter. Corient Private Wealth LLC grew its position in Lam Research by 235.5% in the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after acquiring an additional 3,649,553 shares during the last quarter. Finally, J. Stern & Co. LLP increased its stake in Lam Research by 3,826.9% in the fourth quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company’s stock worth $592,176,000 after purchasing an additional 3,371,283 shares during the period. Institutional investors own 84.61% of the company’s stock.
Lam Research Price Performance
LRCX opened at $311.35 on Friday. The company has a market capitalization of $389.36 billion, a price-to-earnings ratio of 54.05, a PEG ratio of 1.22 and a beta of 1.84. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a 12-month low of $94.11 and a 12-month high of $438.50. The business’s fifty day simple moving average is $339.89 and its 200-day simple moving average is $279.64.
Lam Research Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is 18.06%.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on LRCX. Raymond James Financial set a $425.00 target price on Lam Research in a research report on Wednesday, June 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $390.00 price target on shares of Lam Research in a research note on Thursday, July 30th. Rothschild & Co Redburn lifted their price objective on shares of Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Berenberg Bank boosted their price objective on shares of Lam Research from $265.00 to $335.00 and gave the company a “buy” rating in a research report on Thursday, April 23rd. Finally, JPMorgan Chase & Co. upped their target price on shares of Lam Research from $300.00 to $315.00 and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.47.
Check Out Our Latest Research Report on LRCX
Insider Activity
In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. The trade was a 21.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is currently owned by corporate insiders.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
